Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue

Diabetic Medicine

Volumn 28, Issue 7, 2011, Pages 818-823

  Yue, X ^a,b   Hu, H ^a   Koetsier, M ^c   Graaff, R ^c   Han, C ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Advanced glycation end product reader; Advanced glycation end products; Non invasive assessment; Normal reference value; Skin autofluorescence

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; AUTOFLUORESCENCE; CHINA; CHRONIC DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENDER; GLYCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; NORMAL VALUE; SKIN COLOR; SMOKING HABIT;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHINA; DIABETES MELLITUS; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; SKIN; YOUNG ADULT;

EID: 79958805165     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03217.x     Document Type: Article

References (20)

1. Maillard LC. Action of amino acids on sugars. Formation of melanoidins in a methodical way. C R Acad Sci Ser 2 1912; 154: 66-68.
2. Thornalley PJ. Dicarbonyl intermediates in the Maillard reaction. Ann N Y Acad Sci 2005; 1043: 111-117.
3. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44: 129-146.
4. Smit AJ, Lutgers HL. The clinical relevance of advanced glycation end products (AGE) and recent developments in pharmaceutics to reduce AGE accumulation. Curr Med Chem 2004; 11: 2767-2784.
5. Monnier VM, Bautista O, Kenny D, Sell DR, Fogarty J, Dahms W et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type1 diabetes. Relevance of glycated collagen products versus HbA1c as markers of diabetic complications. Diabetes 1999; 48: 870-880.
6. Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL et al. Simple non-invasive assessment of advanced glycation end product accumulation. Diabetologia 2004; 47: 1324-1330.
7. Meerwaldt R, Hartog JW, Graaff R, Huisman RJ, Links TP, den Hollander NC et al. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16: 3687-3693.
8. den Hollander NC, Mulder DJ, Graaff R, Thorpe SR, Baynes JW, Smit GP et al. Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease1a. J Inherit Metab Dis 2007; 30: 916-923.
9. Lutgers HL, Graaff R, Links TP, Ubink-Veltmaat LJ, Bilo HJ, Gans RO et al. Skin autofluorescence as a non-invasive marker of vascular damage in patients with type2 diabetes. Diabetes Care 2006; 29: 2654-2659.
10. Mulder DJ, van de Water TA, Lutgers HL, Graaff R, Gans RO, Zijlstra F et al. Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation end products: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther 2006; 8: 523-535.
11. Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R. Reference values of skin autofluorescence. Diabetes Technol Ther 2010; 12: 399-403.
12. Meerwaldt R, Links TP, Graaff R, Thorpe SR, Baynes JW, Hartog JW et al. Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 2005; 1043: 290-298.
13. Meerwaldt R, Links TP, Graaff R, Hoogenberg K, Lefrandt JD, Baynes JW et al. Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy. Diabetologia 2005; 48: 1637-1644.
14. Gerrits EG, Lutgers HL, Kleefstra N, Graaff R, Groenier KH, Smit AJ et al. Skin autofluorescence: a tool to identify type2 diabetic patients at risk for developing microvascular complications. Diabetes Care 2008; 31: 517-521.
15. Meerwaldt R, Lutgers HL, Links TP, Graaff R, Baynes JW, Gans RO et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007; 30: 107-112.
16. Hartog JW, de Vries AP, Lutgers HL, Meerwaldt R, Huisman RM, van Son W et al. Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann N Y Acad Sci 2005; 1043: 299-307.
17. Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 1998; 4: 594-601.
18. Kalousová M, Zima T, Popov P, Spacek P, Braun M, Soukupová J et al. Advanced glycation end-products in patients with chronic alcohol misuse. Alcohol Alcohol 2004; 39: 316-320.
19. Magrone T, Panaro MA, Jirillo E, Covelli V. Molecular effects elicited in vitro by red wine on human healthy peripheral blood mononuclear cells: potential therapeutical application of polyphenols to diet-related chronic diseases. Curr Pharm Des 2008; 14: 2758-2766.
20. Jochemsen BM, Mulder DJ, van Doormaal JJ, Mulder G, Volmer M, Graaff R et al. Relation between food and drinking habits, and skin autofluorescence and intima media thickness in subjects at high cardiovascular risk. J Food Nutr Res 2009; 48: 51-58.